peptide 17 TO17 is a broad-spectrum antimicrobial peptide - CA3 drug 17 amino acids near the carboxy terminus of human TACE Unveiling the Multifaceted Roles of Peptide 17: From Cancer Inhibition to Kidney Health

CA3 drug The term "peptide 17" encompasses a diverse range of molecular entities, each with unique properties and potential applications(S8164) YAP-TEAD Inhibitor 1 (Peptide 17). While the specific context of "peptide 17" often points towards YAP-TEAD Inhibitor 1 (Peptide 17), a powerful tool in cancer research, the broader landscape reveals other significant peptides also designated with "17" in their nomenclature, contributing to areas like hypertension management, antimicrobial activity, and even cosmetic applications. This article delves into the scientific understanding and therapeutic potential of various peptides associated with the designation "17," highlighting their mechanisms of action, verifiable parameters, and implications for human health.

At the forefront of current research is YAP-TEAD Inhibitor 1 (Peptide 17). This specific peptide is a potent inhibitor of the YAP-TEAD protein-protein interaction, a crucial pathway implicated in the development and progression of various cancers. Scientific literature consistently identifies this peptide as a YAP-TEAD Inhibitor 1 (Peptide 17) with a remarkable IC50 of 25 nM. This means that only 25 nanomolar concentration of the peptide is required to inhibit 50% of the YAP-TEAD interaction, underscoring its high efficacy. Further research has demonstrated that Peptide 17 was identified with an IC50 of 25 nM, and its binding affinity (Kd = 15 nM) to TEAD1 is even stronger than that of YAP50–171, a longer peptide sequenceMonoclonal Anti-Cytokeratin Peptide 17 antibody produced .... This potent inhibition is achieved through its role in modulating the Hippo signaling pathway, and it is responsible for its inhibitory effects on lung cancer cells by activating the Bcl2/Bax/caspase-9 signal. YAP-TEAD-IN-1 is a 17mer peptide that acts as a competitive inhibitor of the YAP–TEAD interaction. Companies like Selleckchem offer this YAP-TEAD Inhibitor 1 (Peptide 17), with product code Selleckchem #S8164/1mg YAP-TEAD Inhibitor 1 (Peptide 17), making it accessible for researchers globallyMonoclonal Anti-Cytokeratin Peptide 17 antibody produced .... The peptide is often supplied as a solid form and recommended for storage at -20°C.

Beyond its anti-cancer applications, Peptide 17 alleviates early hypertensive renal injury. Studies have shown that this peptide can mitigate the detrimental effects of hypertension on the kidneys by regulating the Hippo/YAP signaling pathway.YAP-TEAD Inhibitor 1 (Peptide 17) - 生化试剂 - 艾美捷科技 Research findings indicate that Peptide 17 alleviates early renal injury in hypertension by reducing systolic blood pressure (SBP) and the urine protein-to-creatinine ratio in hypertensive rat models. This suggests a promising therapeutic avenue for managing kidney damage associated with high blood pressure.

The designation "17" also appears in other important peptides. For instance, TO17 is a broad-spectrum antimicrobial peptide with immunostimulatory properties, demonstrating potential as an antimicrobial agent in aquaculture. In a different domain, EMP17 (Erythropoietin-Mimetic Peptide 17) functions similarly to EPO, the hormone involved in red blood cell productionThe peptideis used for blocking the activity of anti-TACE, C-Terminal(Catalog number AB19027). Incubate the peptide with equal volume of antibody for 30 .... EMP17 activates its receptor by binding to its extracellular domain, thereby mimicking the effects of erythropoietin. Another peptide, Myristoyl Pentapeptide-17, is a cosmetic ingredient known for its ability to promote eyelash growth.YAP-TEAD Inhibitor 1 (Peptide 17) | 0 null | 现货供应 This A five amino acid peptide (Lys-Leu-Ala-Lys-Lys) is modified with myristic acid for enhanced bioavailability, and it directly stimulates keratin genes, leading to thicker and longer lashes.

Furthermore, the term "17" can refer to specific modifications or lengths within larger peptide structures. VASOINTESTINAL PEPTIDE, 17-NLE is one such example, with its molecular formula being C150H244N44O44YAP-TEAD-IN-1 (Peptide 17). In the realm of wound healing, Tiger17 peptide, an an 11 amino acid peptide with a disulfide bridge, has demonstrated potent healing capabilities for skin wounds. The peptide sequence for ADAM 17 Blocking peptide is described as 17 amino acids near the carboxy terminus of human TACE, and it is used for blocking the activity of anti-TACE antibodies.YAP-TEAD Inhibitor 1 (Peptide 17)

The search for "peptide 17" also brings up related terms such as Ca3 yap inhibitor and CA3 drug, indicating ongoing research into other inhibitors of the YAP pathway. Additionally, peptides like Orexin, a neuropeptide regulating arousal and appetite, and IL-17 peptide, used for blocking the activity of IL-17 antibodies, highlight the vast and diverse world of peptide science.

In summary, "peptide 17" is not a singular entity but rather a designation that spans multiple scientific disciplines. From its critical role as a YAP-TEAD protein-protein interaction inhibitor in combating cancer to its potential in managing hypertensive renal disease, and its applications in cosmetics and antimicrobial therapies, the peptides bearing the "17" designation represent significant advancements in our understanding and manipulation of biological processesConclusion: Exogenous expression of peptide 17 activates Bcl2/Bax/caspase-9 signal andis responsible for its inhibitory effects on lung cancer cells. Thus, .... The consistent identification of YAP-TEAD Inhibitor 1 (Peptide 17) with a potent IC50 of 25 nM underscores its therapeutic promise, while ongoing research into other "17" designated peptides continues to expand the frontiers of peptide-based interventions.